← Research hub  ·  securities

CRRFY · Carrefour $3.81 -0.08 (-2.06%) 2026-SEP-18 09:50 EST

My allocation$1,1500.03% of portfolio1 account · as of 2026-SEP-03 · allocation page ↗
AccountSharesPriceValue% of acctCost/shGain $Gain %Target
401K298$3.86$1,1500.05%$3.31$165+16.7%
Research: QT · SA · STK2 mentions
2026-JUL-07 · Bryden Teich · In the Money with Amber Kanwar (host Amber Kanwar) · Neutralmention · ▶ 1:01:27 · source page ↗$3.75

In short: The French grocer Couche-Tard earlier tried and abandoned buying; cited as the pattern of large M&A attempts rebuffed by host countries. Referenced.

1:01:277-Eleven and sort of that playbook because, you probably remember this, remember when they were trying to buy Carrefour the French grocery,

1:01:35didn't like it and then they said okay we're not going to do that, we'll stick to our core business. I think that the thing that's changed in the last quarter or in the

SOD $3.75
2025-MAR-18 · Cole Smead · In the Money with Amber Kanwar (YouTube podcast) · Neutralmention · ▶ 58:29 · source page ↗$2.83

In short: Reference — the French "hypermarket" Couche-Tard took a shot at (and France invoked "food sovereignty" to block). That episode is where Smead got involved in Couche-Tard, because it triggered open-market insider buying and buybacks.

58:29to 65 we're just going to collapse the voting into the non-voting um they didn't do that they did the right thing they collapsed voting and non- voting together and we just wake up as sympatico side by-side Partners I say all that because when we got involved with cushard was when they took a shot at car for the the obviously the French retailer you know what they call hyper hyper Supermarket uh business um that's when we stepped in now why I think a lot of Canadian investors think about cushard as this blue chip high quality

SOD $2.83

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.